CI
45
-3
REGN
38
-2
CVX
43
-3
NOC
41
9
CHD
54
4
IBM
47
-3
CTSH
60
-3
CB
57
2
ROST
57
-3
DTE
43
5
PGR
59
-3
STX
45
-4
MU
28
-3
BMY
55
-8
GD
41
-4
EL
15
-3
V
64
-2
FSLR
44
-2
FITB
60
-5
ESS
62
-3
CI
45
-3
REGN
38
-2
CVX
43
-3
NOC
41
9
CHD
54
4
IBM
47
-3
CTSH
60
-3
CB
57
2
ROST
57
-3
DTE
43
5
PGR
59
-3
STX
45
-4
MU
28
-3
BMY
55
-8
GD
41
-4
EL
15
-3
V
64
-2
FSLR
44
-2
FITB
60
-5
ESS
62
-3
Financhill
Back

LanzaTech Global Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
35

LNZA
LanzaTech Global

Last Price:
1.01
Seasonality Move:
-8.17%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.51
Seasonality Move:
17.03%
Sell
35
LanzaTech Global (LNZA) is a Sell

Is LanzaTech Global a Buy, Sell or Hold?

  • The current LanzaTech Global [LNZA] share price is $1.09. The Score for LNZA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • LNZA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LNZA Stock Price Chart

What is LanzaTech Global's stock price today?

  • The LanzaTech Global share price today is $1.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LNZA is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

LNZA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 27.26 Sell
Chaikin Money Flow: -660352 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.5 - 1.98) Sell
Bollinger Bands (100): (1.44 - 1.96) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

LNZA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.51 Sell
20-day SMA: 1.7 Sell
50-day SMA: 1.71 Sell
200-day SMA: 2.27 Sell
8-day EMA: 1.42 Sell
20-day EMA: 1.62 Sell
50-day EMA: 1.7 Sell
200-day EMA: 2.42 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

LanzaTech Global Earnings Growth & LNZA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.17 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

LanzaTech Global Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):